LIU Jingjing, GONG Yu. Application effect of incentive intervention in treatment of patients with neostomy for rectal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 115-118. DOI: 10.7619/jcmp.202020032
Citation: LIU Jingjing, GONG Yu. Application effect of incentive intervention in treatment of patients with neostomy for rectal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 115-118. DOI: 10.7619/jcmp.202020032

Application effect of incentive intervention in treatment of patients with neostomy for rectal cancer

More Information
  • Received Date: August 22, 2020
  • Available Online: December 21, 2020
  • Published Date: November 12, 2020
  • Objective To investigate the effect of incentive intervention on stoma management efficiency and quality of life in patients with neostomy for rectal cancer. Methods Totally 53 patients with neostomy for rectal cancer from January to December 2018 were selected as control group, and they were treated with conventional nursing intervention. Another 53 patients with neostomy for rectal cancer from January to December 2019 were selected as observation group, and they were treated with incentive nursing intervention. The stoma management efficiency and quality of life at 3 months after discharge were compared between the two groups. Results The scores of stoma care efficiency, stoma self-care efficiency, vitality retention efficiency and social interaction of the observation group were significantly higher than those of the control group at 3 months after discharge(P<0.05). Three months after discharge, the score of functional scale in the observation group was significantly higher than that in the control group, while the score of symptom scale was significantly lower than that in the control group(P<0.05). Conclusion Incentive intervention can improve the self-management efficiency and quality of life in patients with neostomy for rectal cancer.
  • SU X, ZHEN L, ZHU M, et al. Determinants of self-efficacy and quality of life in patients with temporary enterostomy: a crosssectional survey[J]. Journal of Clinical Nursin, 2017, 26(3/4): 477-484.
    李苹瑕. 激励式护理在直肠癌永久性结肠造口病人中的应用[J]. 全科护理, 2018, 16(20): 2515-2516.
    BEKKERS M J, VAN KNIPPENBERG F C, VAN DEN BORNE H W, et al. Prospective evaluation of psychosocial adaptation to stoma surgery: the role of self-efficacy[J]. Psychosomatic Medicine, 1996, 58(2): 183-183.
    阮卉, 尤黎明. 直肠癌永久性结肠造口患者自我效能及影响因素的调查[J]. 护士进修杂志, 2010, 25(11): 1055-1057.
    SPRANGERS M A, TEVELDE A, AARONSON N K. The const ruction and testing of the EORT C Co lorectal Cancerspecific Quality of life Questionnaire Module(QLQ-CR38)[J]. Euro pean Journal of Cancer, 1999, 35(2): 238-247.
    赵煜华, 王俊霞, 张瑞星. 自我效能在肠造口病人护理中的应用研究进展[J]. 护理研究, 2020, 34(4): 683-685.
    鲍玉新, 邵丽萍. 结直肠癌造口患者感知控制与自我护理效能分析[J]. 解放军护理杂志, 2018, 35(13): 25-28.
    贾彩凤, 周慧洁, 黄伶俐. 肠造口患者术后生存质量影响因素的分析[J]. 浙江临床医学, 2020, 22(2): 280-282.
    卞龙艳, 陈晓玲. 激励式护理对直肠癌术后永久性结肠造口病人自我护理能力及生活质量的影响[J]. 全科护理, 2017, 31(21): 90-92.
    刁素娟, 莫冬莲. 激励干预对腹腔镜下直肠癌术后永久结肠造口患者自我效能及生活质量的影响[J]. 现代中西医结合杂志, 2018, 27(30): 3401-3404.
    曹庆锟. 直肠癌术后结肠造口患者实施激励干预护理对患者自我效能和生活质量的影响[J]. 世界临床医学, 2019, 13(2): 102-102

    , 105.
    顾月, 杨靖, 祝宾华. 基于授权理论的干预模式对永久性肠造口患者自我效能和自我接受度的影响[J]. 中华现代护理杂志, 2019, 25(28): 3666-3669.
    何悦, 卞龙艳. 盐城市直肠癌永久性结肠造口患者生活质量的调查研究[J]. 中国卫生产业, 2019, 16(33): 183-184

    , 187.
    陈海红. 激励式护理在直肠癌术后永久性结肠造口患者中的应用效果分析[J]. 中国肛肠病杂志, 2019, 39(8): 67-68.
    张宁, 司徒丽萍, 林翠香, 等. 激励式护理对提高直肠癌术后永久性结肠造口患者生活质量及自我护理能力的作用[J]. 白求恩医学杂志, 2019, 17(1): 89-91.
    李晓伟, 蒋文慧, 张婷, 等. 直肠癌永久性结肠造口患者生存质量现状及其影响因素研究[J]. 护理实践与研究, 2017, 14(11): 85-88.
  • Related Articles

    [1]MENG Lijun, ZHANG Lanfang, QIN Lei, LI Wenjing, SHEN Peijun, CHEN Xu, GUO Xiaohe. Values of serum tumor necrosis factor-α stimulated gene 6 protein and type ⅩⅥ collagen in predicting prognosis of patients with ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 87-90, 95. DOI: 10.7619/jcmp.20243615
    [2]ZHANG Xiaohui. Efficacy of mesalazine alone and live bifidobacterium in combination on the treatment of ulcerative colitis and their effects on TNF-α, IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2018, (3): 112-114. DOI: 10.7619/jcmp.201803032
    [3]WEI Xuefei, XU Pei, CHEN Zairong, GUO Wanhua. Expressions and significance of serum IFN-γ,IL-4, IL-6 and IL-10 in treatment of patients with renal cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (7): 68-70. DOI: 10.7619/jcmp.201507019
    [4]ZHANG Hu, LI Zhi. Effect of Astragalus injection on serum tumor necrosis factor-α, interleukin-6 and angiotensin Ⅱ in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (23): 17-19. DOI: 10.7619/jcmp.201423006
    [5]ZHANG Mingsen, WANG Bin, SUN Yang. Effects of different intravascular volume expansion solutions on serum levels of TNF-α and IL-6 in perioperative patients with craniocerebral trauma[J]. Journal of Clinical Medicine in Practice, 2014, (21): 52-54. DOI: 10.7619/jcmp.201421015
    [6]QIU Zhenqin, DU Zhongde, XU Jiagang. Influence of Danhong injection on the level of serum interleukin-6 and Interleukin-10 in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (19): 17-19. DOI: 10.7619/jcmp.201419006
    [7]BAI Yun, QIU Chuxiong, XUE Weixin, LIN Feng, HUANG Shouyuan, NING Liangzhong, ZHANG Chenghao, YAO Yongzhi. Clinical efficacy of Shenkang Injection and its influence on C-reactive protein and interleukin-6 levels in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2014, (15): 17-19. DOI: 10.7619/jcmp.201415006
    [8]WU Yiping. Clinical significance of serum tumor necrosis factor-α and interleukin-6 in measuring acute intussusception in the infants[J]. Journal of Clinical Medicine in Practice, 2013, (24): 75-77. DOI: 10.7619/jcmp.201324022
    [9]MO Liya, WU Yonghua, WANG Minhong. Association of IL-6, TNF-α and clinical stages,ventilation function in elderly patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (19): 4-6. DOI: 10.7619/jcmp.201319002
    [10]SUN Changjiang, FAN Hui, GE Jianbin. Effect of Xuebijing injection on serum concentrations of TNF-α, IL-1β and IL-6in patients with acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2013, (9): 83-85,90. DOI: 10.7619/jcmp.201309029
  • Cited by

    Periodical cited type(15)

    1. 马治娥,赵文娟,王沛. 不同质子泵抑制剂对胃溃疡患者胃肠激素及氧化应激的影响. 贵州医药. 2024(01): 55-56 .
    2. 孙敏. 四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析. 中国校医. 2024(01): 61-64 .
    3. 黄莉莉,黄晶晶. 奥美拉唑联合纤维蛋白粘合剂在消化性溃疡出血中的应用效果分析. 中国烧伤创疡杂志. 2024(03): 240-244 .
    4. 王燕,宋建国,李红,温爽,付琳璐. 雷尼替丁联合消化内镜对十二指肠溃疡的治疗效果. 中国医药指南. 2024(16): 86-89 .
    5. 刘雅红. 单用质子泵抑制剂治疗消化性溃疡对根除幽门螺杆菌的影响. 中国现代药物应用. 2024(14): 112-114 .
    6. 白玲,赵琴. 血清谷胱甘肽过氧化物酶、脂质过氧化物水平与妊娠期糖尿病及其糖脂代谢异常、胰岛素抵抗和母婴结局的关系. 安徽医药. 2024(11): 2226-2230 .
    7. 陈偲. 小组式知信行健康宣教在消化道溃疡患者中的应用. 江苏卫生事业管理. 2024(10): 1420-1422 .
    8. 王建东. 愈疡健脾方联合质子泵抑制剂治疗脾胃虚寒型消化性溃疡的临床观察. 基层医学论坛. 2024(36): 153-156 .
    9. 陈波,张庆团,黄克锋,杨燕芬,熊弋平. 瑞巴派特四联疗法对幽门螺杆菌阳性消化性溃疡患者血清氧化应激指标和胃蛋白酶原的影响. 现代生物医学进展. 2023(11): 2168-2172 .
    10. 黄小花. 健胃愈疡汤辅助四联疗法治疗十二指肠溃疡的效果及对溃疡面积、胃肠相关指标的影响. 临床合理用药. 2023(29): 81-84 .
    11. 俞洪韵,陈慧丽,朱锋,汪璇,陶治华. 健胃愈疡颗粒联合西咪替丁治疗重症患者应激性溃疡的临床研究. 现代药物与临床. 2023(10): 2506-2510 .
    12. 胡量. 康复新液治疗胃溃疡的临床疗效及对炎性因子、氧化应激和胃黏膜修复作用的影响分析. 现代诊断与治疗. 2023(17): 2543-2545+2556 .
    13. 陆文鹏,陈民,陈洁,郑新梅,董小耘. 基于生物信息学探讨败酱散调控氧化应激缓解克罗恩病的机制. 实用临床医药杂志. 2022(16): 11-17 . 本站查看
    14. 黄以治. 胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果. 中国医药指南. 2022(35): 29-32 .
    15. 张珊珊,刘畅,阴雨龙. 奥美拉唑与雷尼替丁治疗十二指肠溃疡的疗效对比分析. 中外医疗. 2022(31): 136-139 .

    Other cited types(3)

Catalog

    Article views (309) PDF downloads (8) Cited by(18)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return